Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Heeds Calls To Relax Water Quality Threshold For Active Substance Fermentation Media

Executive Summary

The European Medicines Agency’s first revision of its water quality guideline in 18 years has been updated to reflect current expectations for the minimum acceptable quality of water used in the manufacture of active drug substances and finished drug products.

You may also be interested in...

Pharma Concerned By 'Wholesale' Rise In EMA Standard For Pharmaceutical Water

Drug companies have serious environmental- and affordability-related concerns over complying with stricter standards proposed by the European Medicines Agency regarding the quality of water used for manufacturing pharmaceuticals.

Industry Guide Could Ease EU Adoption Of Reverse Osmosis For Pharmaceutical Water

Recent guidance from a pharmaceutical industry group should help manufacturers in the EU make the transition from using highly purified water and steam distillation to other methods for preventing microbiological contamination of pharmaceuticals such as reverse osmosis. The guideline also addresses the cost of using membrane technology versus distillation technology.

EMA Proposal Would Give Popular Alternative For Pharmaceutical Water A Foothold in Europe

The European Medicines Agency is inviting stakeholder feedback on a proposal to allow reverse osmosis as an alternative to steam distillation for making water for injections (WFI) for pharmaceutical manufacturing. EMA also would expand its water quality guideline to cover vaccines and advanced therapy medicinal products such as cell and gene therapies.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts